Skip to main content
Erschienen in: Journal of Bone and Mineral Metabolism 1/2024

06.12.2023 | Original Article

Can TBS reference values be a valid indicator for clinical vertebral fracture? A cross-sectional study

verfasst von: Yasuyuki Omichi, Noriaki Mima, Keizo Wada, Ryo Okada, Yasuaki Tamaki, Daisuke Hamada, Tomohiro Goto, Masatoshi Morimoto, Tsutomu Enomoto, Hiroki Hayashi, Koichi Sairyo

Erschienen in: Journal of Bone and Mineral Metabolism | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Trabecular bone score (TBS) is partially independent of fracture risk. Reference values for TBS have not been established in official guidelines, and thus clinicians often have difficulty interpreting TBS results. This study aimed to investigate whether reference values for TBS could be a valid indicator for clinical vertebral fracture (CVF).

Materials and methods

This cross-sectional study involved 231 women with CVF and 563 women without CVF aged 60–90 years who underwent dual-energy X-ray absorptiometry during 2019–2023. They were divided into osteoporosis, osteopenia, and normal groups according to bone mineral density of the lumbar spine. Reference values for TBS were defined as low (≤ 1.23), intermediate (1.23–1.31), and high (≥ 1.31).

Results

Among patients without anti-osteoporosis treatment (n = 476), the proportion with low TBS was 36.7% in the CVF group and 10.7% in the control group. The proportion with CVF was higher in the low TBS group than in the intermediate and high TBS groups, especially in the osteoporosis group (p < 0.001). The odds ratio for CVF was higher in the low TBS group than in the intermediate and high especially in patients with normal BMD and osteoporosis. The TBS cut-off values for incidence of CVF in the osteoporosis, osteopenia, and normal groups were 1.224, 1.319, and 1.322, respectively.

Conclusions

The reference value for low TBS (≤ 1.23) was useful as an indicator for CVF, especially in patients with osteoporosis. It is expected that reference values for TBS will be established in official guidelines in the future.
Literatur
1.
Zurück zum Zitat (2001) Osteoporosis prevention, diagnosis, and therapy. Jama 285:785–795 (2001) Osteoporosis prevention, diagnosis, and therapy. Jama 285:785–795
2.
Zurück zum Zitat Brown JP, Engelke K, Keaveny TM, Chines A, Chapurlat R, Foldes AJ, Nogues X, Civitelli R, De Villiers T, Massari F, Zerbini CAF, Wang Z, Oates MK, Recknor C, Libanati C (2021) Romosozumab improves lumbar spine bone mass and bone strength parameters relative to alendronate in postmenopausal women: results from the Active-Controlled Fracture Study in Postmenopausal Women With Osteoporosis at High Risk (ARCH) trial. J Bone Miner Res 36:2139–2152CrossRefPubMed Brown JP, Engelke K, Keaveny TM, Chines A, Chapurlat R, Foldes AJ, Nogues X, Civitelli R, De Villiers T, Massari F, Zerbini CAF, Wang Z, Oates MK, Recknor C, Libanati C (2021) Romosozumab improves lumbar spine bone mass and bone strength parameters relative to alendronate in postmenopausal women: results from the Active-Controlled Fracture Study in Postmenopausal Women With Osteoporosis at High Risk (ARCH) trial. J Bone Miner Res 36:2139–2152CrossRefPubMed
3.
Zurück zum Zitat Kanis JA (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group Osteoporos Int 4:368–381CrossRef Kanis JA (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group Osteoporos Int 4:368–381CrossRef
4.
Zurück zum Zitat Johnell O, Kanis JA, Oden A, Johansson H, De Laet C, Delmas P, Eisman JA, Fujiwara S, Kroger H, Mellstrom D, Meunier PJ, Melton LJ 3rd, O’Neill T, Pols H, Reeve J, Silman A, Tenenhouse A (2005) Predictive value of BMD for hip and other fractures. J Bone Miner Res 20:1185–1194CrossRefPubMed Johnell O, Kanis JA, Oden A, Johansson H, De Laet C, Delmas P, Eisman JA, Fujiwara S, Kroger H, Mellstrom D, Meunier PJ, Melton LJ 3rd, O’Neill T, Pols H, Reeve J, Silman A, Tenenhouse A (2005) Predictive value of BMD for hip and other fractures. J Bone Miner Res 20:1185–1194CrossRefPubMed
5.
Zurück zum Zitat Kadri A, Binkley N, Daffner SD, Anderson PA (2023) Fracture in patients with normal bone mineral density: an evaluation of the american orthopaedic association’s own the bone registry. J Bone Joint Surg Am 105:128–136CrossRefPubMed Kadri A, Binkley N, Daffner SD, Anderson PA (2023) Fracture in patients with normal bone mineral density: an evaluation of the american orthopaedic association’s own the bone registry. J Bone Joint Surg Am 105:128–136CrossRefPubMed
6.
Zurück zum Zitat Hans D, Goertzen AL, Krieg MA, Leslie WD (2011) Bone microarchitecture assessed by TBS predicts osteoporotic fractures independent of bone density: the Manitoba study. J Bone Miner Res 26:2762–2769CrossRefPubMed Hans D, Goertzen AL, Krieg MA, Leslie WD (2011) Bone microarchitecture assessed by TBS predicts osteoporotic fractures independent of bone density: the Manitoba study. J Bone Miner Res 26:2762–2769CrossRefPubMed
7.
Zurück zum Zitat Richards C, Leslie WD (2022) Trabecular Bone Score in Rheumatic Disease. Curr Rheumatol Rep 24:81–87CrossRefPubMed Richards C, Leslie WD (2022) Trabecular Bone Score in Rheumatic Disease. Curr Rheumatol Rep 24:81–87CrossRefPubMed
8.
Zurück zum Zitat Silva BC, Leslie WD, Resch H, Lamy O, Lesnyak O, Binkley N, McCloskey EV, Kanis JA, Bilezikian JP (2014) Trabecular bone score: a noninvasive analytical method based upon the DXA image. J Bone Miner Res 29:518–530CrossRefPubMed Silva BC, Leslie WD, Resch H, Lamy O, Lesnyak O, Binkley N, McCloskey EV, Kanis JA, Bilezikian JP (2014) Trabecular bone score: a noninvasive analytical method based upon the DXA image. J Bone Miner Res 29:518–530CrossRefPubMed
9.
Zurück zum Zitat Cozadd AJ, Schroder LK, Switzer JA (2021) Fracture Risk Assessment: An Update. J Bone Joint Surg Am 103:1238–1246CrossRefPubMed Cozadd AJ, Schroder LK, Switzer JA (2021) Fracture Risk Assessment: An Update. J Bone Joint Surg Am 103:1238–1246CrossRefPubMed
10.
Zurück zum Zitat Cianferotti L, Cipriani C, Corbetta S, Corona G, Defeudis G, Lania AG, Messina C, Napoli N, Mazziotti G (2023) Bone quality in endocrine diseases: determinants and clinical relevance. J Endocrinol Invest Cianferotti L, Cipriani C, Corbetta S, Corona G, Defeudis G, Lania AG, Messina C, Napoli N, Mazziotti G (2023) Bone quality in endocrine diseases: determinants and clinical relevance. J Endocrinol Invest
11.
Zurück zum Zitat Shevroja E, Cafarelli FP, Guglielmi G, Hans D (2021) DXA parameters, Trabecular Bone Score (TBS) and Bone Mineral Density (BMD), in fracture risk prediction in endocrine-mediated secondary osteoporosis. Endocrine 74:20–28CrossRefPubMedPubMedCentral Shevroja E, Cafarelli FP, Guglielmi G, Hans D (2021) DXA parameters, Trabecular Bone Score (TBS) and Bone Mineral Density (BMD), in fracture risk prediction in endocrine-mediated secondary osteoporosis. Endocrine 74:20–28CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Fujimaki H, Tomioka M, Kanoshima Y, Morita A, Yamori T, Inaba Y (2022) Accuracy of the Fracture Risk Assessment Tool for judging pharmacotherapy initiation for primary osteoporosis. J Bone Miner Metab 40:860–868CrossRefPubMed Fujimaki H, Tomioka M, Kanoshima Y, Morita A, Yamori T, Inaba Y (2022) Accuracy of the Fracture Risk Assessment Tool for judging pharmacotherapy initiation for primary osteoporosis. J Bone Miner Metab 40:860–868CrossRefPubMed
13.
Zurück zum Zitat Silva BC, Broy SB, Boutroy S, Schousboe JT, Shepherd JA, Leslie WD (2015) Fracture Risk Prediction by Non-BMD DXA Measures: the 2015 ISCD Official Positions Part 2: Trabecular Bone Score. J Clin Densitom 18:309–330CrossRefPubMed Silva BC, Broy SB, Boutroy S, Schousboe JT, Shepherd JA, Leslie WD (2015) Fracture Risk Prediction by Non-BMD DXA Measures: the 2015 ISCD Official Positions Part 2: Trabecular Bone Score. J Clin Densitom 18:309–330CrossRefPubMed
14.
Zurück zum Zitat Leslie WD, Shevroja E, Johansson H, McCloskey EV, Harvey NC, Kanis JA, Hans D (2018) Risk-equivalent T-score adjustment for using lumbar spine trabecular bone score (TBS): the Manitoba BMD registry. Osteoporos Int 29:751–758CrossRefPubMedPubMedCentral Leslie WD, Shevroja E, Johansson H, McCloskey EV, Harvey NC, Kanis JA, Hans D (2018) Risk-equivalent T-score adjustment for using lumbar spine trabecular bone score (TBS): the Manitoba BMD registry. Osteoporos Int 29:751–758CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Camacho PM, Petak SM, Binkley N, Diab DL, Eldeiry LS, Farooki A, Harris ST, Hurley DL, Kelly J, Lewiecki EM, Pessah-Pollack R, McClung M, Wimalawansa SJ, Watts NB (2020) American Association Of Clinical Endocrinologists/American College Of Endocrinology Clinical Practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis-2020 update. Endocr Pract 26:1–46CrossRefPubMed Camacho PM, Petak SM, Binkley N, Diab DL, Eldeiry LS, Farooki A, Harris ST, Hurley DL, Kelly J, Lewiecki EM, Pessah-Pollack R, McClung M, Wimalawansa SJ, Watts NB (2020) American Association Of Clinical Endocrinologists/American College Of Endocrinology Clinical Practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis-2020 update. Endocr Pract 26:1–46CrossRefPubMed
16.
Zurück zum Zitat McCloskey EV, Odén A, Harvey NC, Leslie WD, Hans D et al (2016) A Meta-Analysis of Trabecular Bone Score in Fracture Risk Prediction and Its Relationship to FRAX. J Bone Miner Res 31:940–948CrossRefPubMed McCloskey EV, Odén A, Harvey NC, Leslie WD, Hans D et al (2016) A Meta-Analysis of Trabecular Bone Score in Fracture Risk Prediction and Its Relationship to FRAX. J Bone Miner Res 31:940–948CrossRefPubMed
17.
Zurück zum Zitat Goel H, Binkley N, Hans D, Leslie WD (2023) Bone density and trabecular bone score to predict fractures in adults aged 20–39 years: a registry-based study. Osteoporos Int Goel H, Binkley N, Hans D, Leslie WD (2023) Bone density and trabecular bone score to predict fractures in adults aged 20–39 years: a registry-based study. Osteoporos Int
18.
Zurück zum Zitat Khan MA, Jennings JW, Baker JC, Smolock AR, Shah LM et al (2023) ACR Appropriateness Criteria® Management of Vertebral Compression Fractures: 2022 Update. J Am Coll Radiol 20:S102-s124CrossRefPubMed Khan MA, Jennings JW, Baker JC, Smolock AR, Shah LM et al (2023) ACR Appropriateness Criteria® Management of Vertebral Compression Fractures: 2022 Update. J Am Coll Radiol 20:S102-s124CrossRefPubMed
19.
Zurück zum Zitat Genant HK, Wu CY, van Kuijk C, Nevitt MC (1993) Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8:1137–1148CrossRefPubMed Genant HK, Wu CY, van Kuijk C, Nevitt MC (1993) Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8:1137–1148CrossRefPubMed
20.
Zurück zum Zitat Shuhart CR, Yeap SS, Anderson PA, Jankowski LG, Lewiecki EM, Morse LR, Rosen HN, Weber DR, Zemel BS, Shepherd JA (2019) Executive Summary of the 2019 ISCD Position Development Conference on Monitoring Treatment, DXA Cross-calibration and Least Significant Change, Spinal Cord Injury, Peri-prosthetic and Orthopedic Bone Health, Transgender Medicine, and Pediatrics. J Clin Densitom 22:453–471 Shuhart CR, Yeap SS, Anderson PA, Jankowski LG, Lewiecki EM, Morse LR, Rosen HN, Weber DR, Zemel BS, Shepherd JA (2019) Executive Summary of the 2019 ISCD Position Development Conference on Monitoring Treatment, DXA Cross-calibration and Least Significant Change, Spinal Cord Injury, Peri-prosthetic and Orthopedic Bone Health, Transgender Medicine, and Pediatrics. J Clin Densitom 22:453–471
21.
Zurück zum Zitat Borgen TT, Bjørnerem Å, Solberg LB, Andreasen C, Brunborg C et al (2019) High prevalence of vertebral fractures and low trabecular bone score in patients with fragility fractures: A cross-sectional sub-study of NoFRACT. Bone 122:14–21CrossRefPubMed Borgen TT, Bjørnerem Å, Solberg LB, Andreasen C, Brunborg C et al (2019) High prevalence of vertebral fractures and low trabecular bone score in patients with fragility fractures: A cross-sectional sub-study of NoFRACT. Bone 122:14–21CrossRefPubMed
23.
Zurück zum Zitat Agarwal K, Cherian KE, Kapoor N, Paul TV (2022) OSTA as a screening tool to predict osteoporosis in Indian postmenopausal women - a nationwide study. Arch Osteoporos 17:121CrossRefPubMed Agarwal K, Cherian KE, Kapoor N, Paul TV (2022) OSTA as a screening tool to predict osteoporosis in Indian postmenopausal women - a nationwide study. Arch Osteoporos 17:121CrossRefPubMed
24.
Zurück zum Zitat Kuriakose C, Cherian KE, Jebasingh F, Kapoor N, Asha HS, Jose A, Thomas N, Paul TV (2022) The prevalence of vertebral fractures among Indian perimenopausal women and its association with ovarian biomarkers. J Bone Miner Metab 40:142–149CrossRefPubMed Kuriakose C, Cherian KE, Jebasingh F, Kapoor N, Asha HS, Jose A, Thomas N, Paul TV (2022) The prevalence of vertebral fractures among Indian perimenopausal women and its association with ovarian biomarkers. J Bone Miner Metab 40:142–149CrossRefPubMed
25.
Zurück zum Zitat Vinolas H, Grouthier V, Mehsen-Cetre N, Boisson A, Winzenrieth R, Schaeverbeke T, Mesguich C, Bordenave L, Tabarin A (2018) Assessment of vertebral microarchitecture in overt and mild Cushing’s syndrome using trabecular bone score. Clin Endocrinol (Oxf) 89:148–154CrossRefPubMed Vinolas H, Grouthier V, Mehsen-Cetre N, Boisson A, Winzenrieth R, Schaeverbeke T, Mesguich C, Bordenave L, Tabarin A (2018) Assessment of vertebral microarchitecture in overt and mild Cushing’s syndrome using trabecular bone score. Clin Endocrinol (Oxf) 89:148–154CrossRefPubMed
26.
Zurück zum Zitat Pothuaud L, Carceller P, Hans D (2008) Correlations between grey-level variations in 2D projection images (TBS) and 3D microarchitecture: applications in the study of human trabecular bone microarchitecture. Bone 42:775–787CrossRefPubMed Pothuaud L, Carceller P, Hans D (2008) Correlations between grey-level variations in 2D projection images (TBS) and 3D microarchitecture: applications in the study of human trabecular bone microarchitecture. Bone 42:775–787CrossRefPubMed
27.
28.
Zurück zum Zitat Kužma M, Hans D, Koller T, Némethová E, Jackuliak P, Killinger Z, Resch H, Payer J (2018) Less strict intervention thresholds for the FRAX and TBS-adjusted FRAX predict clinical fractures in osteopenic postmenopausal women with no prior fractures. J Bone Miner Metab 36:580–588CrossRefPubMed Kužma M, Hans D, Koller T, Némethová E, Jackuliak P, Killinger Z, Resch H, Payer J (2018) Less strict intervention thresholds for the FRAX and TBS-adjusted FRAX predict clinical fractures in osteopenic postmenopausal women with no prior fractures. J Bone Miner Metab 36:580–588CrossRefPubMed
29.
Zurück zum Zitat Goel H, Binkley N, Hans D, Leslie WD (2023) Fracture risk gradient assessed by categories of bone mineral density and trabecular bone score: the Manitoba BMD Registry. Arch Osteoporos 18:73CrossRefPubMed Goel H, Binkley N, Hans D, Leslie WD (2023) Fracture risk gradient assessed by categories of bone mineral density and trabecular bone score: the Manitoba BMD Registry. Arch Osteoporos 18:73CrossRefPubMed
30.
Zurück zum Zitat Iki M, Tamaki J, Kadowaki E, Sato Y, Dongmei N, Winzenrieth R, Kagamimori S, Kagawa Y, Yoneshima H (2014) Trabecular bone score (TBS) predicts vertebral fractures in Japanese women over 10 years independently of bone density and prevalent vertebral deformity: the Japanese Population-Based Osteoporosis (JPOS) cohort study. J Bone Miner Res 29:399–407CrossRefPubMed Iki M, Tamaki J, Kadowaki E, Sato Y, Dongmei N, Winzenrieth R, Kagamimori S, Kagawa Y, Yoneshima H (2014) Trabecular bone score (TBS) predicts vertebral fractures in Japanese women over 10 years independently of bone density and prevalent vertebral deformity: the Japanese Population-Based Osteoporosis (JPOS) cohort study. J Bone Miner Res 29:399–407CrossRefPubMed
31.
Zurück zum Zitat Popp AW, Meer S, Krieg MA, Perrelet R, Hans D, Lippuner K (2016) Bone mineral density (BMD) and vertebral trabecular bone score (TBS) for the identification of elderly women at high risk for fracture: the SEMOF cohort study. Eur Spine J 25:3432–3438CrossRefPubMed Popp AW, Meer S, Krieg MA, Perrelet R, Hans D, Lippuner K (2016) Bone mineral density (BMD) and vertebral trabecular bone score (TBS) for the identification of elderly women at high risk for fracture: the SEMOF cohort study. Eur Spine J 25:3432–3438CrossRefPubMed
Metadaten
Titel
Can TBS reference values be a valid indicator for clinical vertebral fracture? A cross-sectional study
verfasst von
Yasuyuki Omichi
Noriaki Mima
Keizo Wada
Ryo Okada
Yasuaki Tamaki
Daisuke Hamada
Tomohiro Goto
Masatoshi Morimoto
Tsutomu Enomoto
Hiroki Hayashi
Koichi Sairyo
Publikationsdatum
06.12.2023
Verlag
Springer Nature Singapore
Erschienen in
Journal of Bone and Mineral Metabolism / Ausgabe 1/2024
Print ISSN: 0914-8779
Elektronische ISSN: 1435-5604
DOI
https://doi.org/10.1007/s00774-023-01476-1

Weitere Artikel der Ausgabe 1/2024

Journal of Bone and Mineral Metabolism 1/2024 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.